Kansas City Business Journal -- Dr. Nicholas Franano might be an unlikely fan of the Kansas Bioscience Authority. The Kansas City pharmaceutical entrepreneur serves on the board of Missouri Technology Corp. Like the KBA, the Missouri nonprofit competes for outside research financing in a quest to convert academic discoveries into new companies that create jobs.
